Brief: United Laboratories International Says FDA Approves IND Applications For UBT48128 Tablets
11/08/2026 11:09
BRIEF-United Laboratories International Says FDA Approves IND Applications For UBT48128 Tablets Aug 11 (Reuters) - United Laboratories International Holdings Ltd 3933.HK:
FDA APPROVES IND APPLICATIONS FOR UBT48128 TABLETS FOR OVERWEIGHT, OBESITY AND TYPE 2 DIABETES
FDA APPROVAL OF IND FOR GROUP'S PRODUCT UBT48128 TABLETS
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million